Researchers from the Center of Excellence in Marine Biotechnology at Sultan Qaboos University (SQU), in collaboration with Macro Algae Industries, have launched a pilot seaweed farm near the Al Sawadi Islands in Barka to evaluate the commercial feasibility of cultivating native seaweed species in Omani waters.

Following almost half a decade of dedicated research and extensive field work across Europe, the Safeguard project has officially ended.

A team led by researchers at The University of Texas at Austin has mapped the molecular structure, at the highest resolution yet, for a protein complex the Andes virus uses to infect host cells. Having this structure, essentially a 3D map showing the complex shapes of molecules at the nanoscale, is a precursor for vaccine development and the creation of antibody therapies.

German and Costa Rican scientists launch a new partnership to explore one of the world's richest biodiversity hotspots. Prof. Meike Piepenbring, mycologist at Goethe University Frankfurt, has secured funding from the Federal Ministry of Research, Technology, and Space (BMFTR) to establish the German-Costa Rican Network for Tropical Biodiversity Research (GeCoBio). Over the next three years, €450,000 will support the development of this collaboration.

Researchers working with Professor Ralf Erdmann at Ruhr University Bochum, Germany, have discovered a critical vulnerability shared by the pathogens that cause African sleeping sickness, Chagas disease, and leishmaniasis. The PEX38 protein plays a crucial role in the formation of certain organelles of the trypanosomes that are essential for their energy supply. Because humans do not require this protein, it represents a promising target for new treatments against tropical diseases that affect over one billion people worldwide every year. Current treatments are often limited by high toxicity and increasing drug resistance. The team led by Ralf Erdmann reports its findings in the journal Proceedings of the National Academy of Sciences (PNAS) from February 26, 2026. 

In the era of climate crisis, hydrogen vehicles are emerging as an alternative for eco-friendly mobility. However, the fuel cell, known as the ‘heart of the hydrogen car,’ still faces limitations of high cost and short lifespan. The core cause is the platinum catalyst. While it is a decisive material for generating electricity, the reaction is slow, performance degrades over time, and manufacturing costs are high. Korean researchers have presented a clue to solving this difficult problem.

The Alliance for Clinical Trials in Oncology will host a free, public webinar on Monday, March 16, 2026, from 1 pm to 2 pm CT showcasing key cancer research from Alliance investigators presented at the 2025 American Society of Hematology (ASH) and the San Antonio Breast Cancer Symposium (SABCS) meetings. The virtual meeting will highlight recent clinical advances impacting treatment for people living with breast cancer, multiple myeloma, and leukemia.